Response to "Results, rhetoric, and randomized trials: the case of donepezil".
Lisi, Donna
Response to "Results, rhetoric, and randomized trials: the case of donepezil". [electronic resource] - Journal of the American Geriatrics Society Jul 2009 - 1317-8; author reply 1318 p. digital
Publication Type: Letter; Comment
1532-5415
10.1111/j.1532-5415.2009.02331.x doi
Advertising
Aged
Alzheimer Disease--drug therapy
Conflict of Interest
Donepezil
Drug Industry--economics
Drug Utilization--statistics & numerical data
Economic Competition
Evidence-Based Medicine--statistics & numerical data
Humans
Indans--adverse effects
Manuscripts, Medical as Topic
Marketing
Nootropic Agents--adverse effects
Piperidines--adverse effects
Psycholinguistics
Randomized Controlled Trials as Topic
Response to "Results, rhetoric, and randomized trials: the case of donepezil". [electronic resource] - Journal of the American Geriatrics Society Jul 2009 - 1317-8; author reply 1318 p. digital
Publication Type: Letter; Comment
1532-5415
10.1111/j.1532-5415.2009.02331.x doi
Advertising
Aged
Alzheimer Disease--drug therapy
Conflict of Interest
Donepezil
Drug Industry--economics
Drug Utilization--statistics & numerical data
Economic Competition
Evidence-Based Medicine--statistics & numerical data
Humans
Indans--adverse effects
Manuscripts, Medical as Topic
Marketing
Nootropic Agents--adverse effects
Piperidines--adverse effects
Psycholinguistics
Randomized Controlled Trials as Topic